Oct 26 (Reuters) – Eris Lifesciences Ltd: * SEPT-QUARTER CONSOL NET PROFIT 1.84 BILLION RUPEES * SEPT-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 8.92 BILLION RUPEES Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Guidewire to buy UK insurance AI firm hyperexponential in deal worth up to $2.1 billion
(Corrects to removes extraneous word in fifth bullet) Oct 27 (Reuters) - Insurance software maker…
Stocks rise and oil slips on Middle East diplomacy efforts ahead of Big Tech earnings
By Johann M Cherian and Ankur Banerjee Oct 27 (Reuters) - Global stocks rose and…
₹400 crore unexecuted order book expected to be completed this fiscal year provides a strong…
